NEW YORK, November 4, 2005—Many of the world’s leading experts on the varicella-zoster virus (VZV)—which causes chickenpox (varicella), shingles (herpes zoster) and postherpetic neuralgia (PHN)—will convene in New York on November 7 to discuss global VZV issues, including: the impact of the vaccine in disease reduction; the FDA’s recent approval of MMRV; the effectiveness of an experimental shingles vaccine in reducing the incidence of shingles; and the poten
New Canaan, CT -- The publication of A Crack in the Shield: Our Unvaccinated Children
WASHINGTON, D.C., Sept. 7, 2005 – The Albert B. Sabin Vaccine Institute (Sabin), a leader in promoting the development and use of safe and effective vaccines to prevent disease, announced receipt of a grant of $150,000 from the Bill & Melinda Gates Foundation for the sponsorship of a vaccine policy colloquium to be held at Cold Spring Harbor, Long Island, New York, October 19-21, 2005.
NEW CANAAN, CT—Thirty-five leading cancer vaccine researchers met to consider medical progress in treating cancer with vaccines during a three-day meeting convened by New Canaan’s Sabin Vaccine Institute (Sabin) held this past June.
NEW CANAAN, CT, JUNE 29, 2005 —The Sabin Vaccine Institute will recognize extraordinary contributors to disease research and healthcare innovations at its black-tie gala beginning at 6:30 p.m. on June 29, 2005 at the University Club in New York City.